DEFINITIVE PROXY STATEMENT

Company

ABVC BIOPHARMA, INC.

Filed

April 27, 2022

Period of Report

May 20, 2022

Accession Number

0001213900-22-021802

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →